Cocrystal Pharma, Inc.
General ticker "COCP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $16.3M (TTM average)
Cocrystal Pharma, Inc. does not follow the US Stock Market performance with the rate: -21.3%.
Estimated limits based on current volatility of 3.0%: low 1.10$, high 1.17$
Factors to consider:
- Total employees count: 12 as of 2022
- Top business risk factors: Pandemic risks, Third-party risks, Labor/talent shortage/retention, Operational and conduct risks, Regulatory and compliance
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.41$, 4.04$]
- 2025-12-31 to 2026-12-31 estimated range: [0.97$, 2.90$]
Financial Metrics affecting the COCP estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -64.78 <= 0.04
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 70.77 > 64.17
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.03 > -0.62
Short-term COCP quotes
Long-term COCP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $38.83MM | $18.56MM | $17.88MM |
| Operating Income | $-38.83MM | $-18.56MM | $-17.88MM |
| Non-Operating Income | $-0.01MM | $0.57MM | $0.37MM |
| Interest Expense | $0.00MM | $0.64MM | $0.00MM |
| R&D Expense | $12.39MM | $15.17MM | $12.54MM |
| Income(Loss) | $-38.84MM | $-17.98MM | $-17.50MM |
| Profit(Loss)* | $-38.84MM | $-17.98MM | $-17.50MM |
| Stockholders Equity | $39.57MM | $26.38MM | $9.52MM |
| Assets | $40.84MM | $31.26MM | $13.46MM |
| Operating Cash Flow | $-21.43MM | $-14.67MM | $-16.48MM |
| Capital expenditure | $0.07MM | $0.12MM | $0.01MM |
| Investing Cash Flow | $-0.07MM | $-0.12MM | $-0.01MM |
| Financing Cash Flow | $-0.03MM | $3.99MM | $0.00MM |
| Earnings Per Share** | $-4.77 | $-1.86 | $-1.72 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.